ArticleFrontiers in oncology2020

Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling.

Huiying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.